During the past decade, Jong Yeop Kim conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Jong Yeop Kim" are "Drug Usage" (1 trials) and "Intubation" (1 trials). Many other conditions were trialed in "Jong Yeop Kim" in a lesser frequency.

Most popular intervention types in "Jong Yeop Kim" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Macintosh laryngoscopy" (1 trials), "McGrath videolaryngoscopy" (1 trials), "Pentax videolaryngoscopy" (1 trials) and "Remifentanil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jong Yeop Kim" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Jong Yeop Kim". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Jong Yeop Kim, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jong Yeop Kim, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".